221 related articles for article (PubMed ID: 28135894)
21. [Genetic and phenotypic analysis of a patient with phosphogylcerate dehydrogenase deficiency].
Tao Z; Lu F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Feb; 38(2):170-173. PubMed ID: 33565074
[TBL] [Abstract][Full Text] [Related]
22. Disturbed phospholipid metabolism in serine biosynthesis defects revealed by metabolomic profiling.
Glinton KE; Benke PJ; Lines MA; Geraghty MT; Chakraborty P; Al-Dirbashi OY; Jiang Y; Kennedy AD; Grotewiel MS; Sutton VR; Elsea SH; El-Hattab AW
Mol Genet Metab; 2018 Mar; 123(3):309-316. PubMed ID: 29269105
[TBL] [Abstract][Full Text] [Related]
23. Adult diagnosis of congenital serine biosynthesis defect: A treatable cause of progressive neuropathy.
Debs S; Ferreira CR; Groden C; Kim HJ; King KA; King MC; Lehky T; Cowen EW; Brown LH; Merideth M; Owen CM; Macnamara E; Toro C; Gahl WA; Soldatos A
Am J Med Genet A; 2021 Jul; 185(7):2102-2107. PubMed ID: 34089226
[TBL] [Abstract][Full Text] [Related]
24. Neu-Laxova syndrome: a prenatal diagnosis.
Dhillon P; Bofill JA
J Miss State Med Assoc; 2011 Oct; 52(10):307-9. PubMed ID: 22268252
[TBL] [Abstract][Full Text] [Related]
25. Beneficial effects of L-serine and glycine in the management of seizures in 3-phosphoglycerate dehydrogenase deficiency.
de Koning TJ; Duran M; Dorland L; Gooskens R; Van Schaftingen E; Jaeken J; Blau N; Berger R; Poll-The BT
Ann Neurol; 1998 Aug; 44(2):261-5. PubMed ID: 9708551
[TBL] [Abstract][Full Text] [Related]
26. 3-phosphoglycerate dehydrogenase deficiency: a case report of a treatable cause of seizures.
Coşkun T; Aydin HI; Kiliç M; Dursun A; Haliloğlu G; Topaloğlu H; Karli-Oğuz K; de Koning TJ
Turk J Pediatr; 2009; 51(6):587-92. PubMed ID: 20196394
[TBL] [Abstract][Full Text] [Related]
27. An update on serine deficiency disorders.
van der Crabben SN; Verhoeven-Duif NM; Brilstra EH; Van Maldergem L; Coskun T; Rubio-Gozalbo E; Berger R; de Koning TJ
J Inherit Metab Dis; 2013 Jul; 36(4):613-9. PubMed ID: 23463425
[TBL] [Abstract][Full Text] [Related]
28. Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency.
de Koning TJ; Jaeken J; Pineda M; Van Maldergem L; Poll-The BT; van der Knaap MS
Neuropediatrics; 2000 Dec; 31(6):287-92. PubMed ID: 11508546
[TBL] [Abstract][Full Text] [Related]
29. Phosphoserine aminotransferase deficiency: imaging findings in a child with congenital microcephaly.
Shapira Zaltsberg G; McMillan HJ; Miller E
J Matern Fetal Neonatal Med; 2020 Mar; 33(6):1033-1035. PubMed ID: 30122079
[TBL] [Abstract][Full Text] [Related]
30. Neu-Laxova syndrome presenting prenatally with increased nuchal translucency and cystic hygroma: The utility of exome sequencing in deciphering the diagnosis.
Bourque DK; Cloutier M; Kernohan KD; Bareke E; Grynspan D; Michaud J; ; Boycott KM
Am J Med Genet A; 2019 May; 179(5):813-816. PubMed ID: 30838783
[TBL] [Abstract][Full Text] [Related]
31. Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency.
de Koning TJ; Klomp LW; van Oppen AC; Beemer FA; Dorland L; van den Berg I; Berger R
Lancet; 2004 Dec 18-31; 364(9452):2221-2. PubMed ID: 15610810
[TBL] [Abstract][Full Text] [Related]
32. [Essentiality of de novo L-serine synthesis for embryonic development and higher functions].
Furuya S; Sayano T; Esaki K
Seikagaku; 2014 Jun; 86(3):372-81. PubMed ID: 25073376
[No Abstract] [Full Text] [Related]
33. Amino acid synthesis deficiencies.
de Koning TJ
J Inherit Metab Dis; 2017 Jul; 40(4):609-620. PubMed ID: 28653176
[TBL] [Abstract][Full Text] [Related]
34. 3-Phosphoglycerate dehydrogenase deficiency: an inborn error of serine biosynthesis.
Jaeken J; Detheux M; Van Maldergem L; Foulon M; Carchon H; Van Schaftingen E
Arch Dis Child; 1996 Jun; 74(6):542-5. PubMed ID: 8758134
[TBL] [Abstract][Full Text] [Related]
35. Asparagine synthetase deficiency detected by whole exome sequencing causes congenital microcephaly, epileptic encephalopathy and psychomotor delay.
Ben-Salem S; Gleeson JG; Al-Shamsi AM; Islam B; Hertecant J; Ali BR; Al-Gazali L
Metab Brain Dis; 2015 Jun; 30(3):687-94. PubMed ID: 25227173
[TBL] [Abstract][Full Text] [Related]
36. Second trimester diagnosis of Neu Laxova syndrome.
Shivarajan MA; Suresh S; Jagadeesh S; Lata S; Bhat L
Prenat Diagn; 2003 Jan; 23(1):21-4. PubMed ID: 12533807
[TBL] [Abstract][Full Text] [Related]
37. Novel mutations in 3-phosphoglycerate dehydrogenase (PHGDH) are distributed throughout the protein and result in altered enzyme kinetics.
Tabatabaie L; de Koning TJ; Geboers AJ; van den Berg IE; Berger R; Klomp LW
Hum Mutat; 2009 May; 30(5):749-56. PubMed ID: 19235232
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic heterogeneity and adverse effects of serine treatment in 3-phosphoglycerate dehydrogenase deficiency: report on two siblings.
Häusler MG; Jaeken J; Mönch E; Ramaekers VT
Neuropediatrics; 2001 Aug; 32(4):191-5. PubMed ID: 11571699
[TBL] [Abstract][Full Text] [Related]
39. A serine synthesis defect presenting with a Charcot-Marie-Tooth-like polyneuropathy.
Méneret A; Wiame E; Marelli C; Lenglet T; Van Schaftingen E; Sedel F
Arch Neurol; 2012 Jul; 69(7):908-11. PubMed ID: 22393170
[TBL] [Abstract][Full Text] [Related]
40. Neu Laxova syndrome and megacystis in the first trimester: Broadening the fetal phenotype.
Bourgon N; Chen R; Grangé G; Grotto S; Molac C; Loeuillet L; Attié-Bitach T
Prenat Diagn; 2023 Dec; 43(13):1666-1670. PubMed ID: 37964427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
